The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches
dc.contributor.author | Pandya, Pankita H. | |
dc.contributor.author | Murrary, Mary E. | |
dc.contributor.author | Pollok, Karen E. | |
dc.contributor.author | Renbarger, Jamie L. | |
dc.contributor.department | Department of Medicine, IU School of Medicine | en_US |
dc.date.accessioned | 2017-05-03T16:56:23Z | |
dc.date.available | 2017-05-03T16:56:23Z | |
dc.date.issued | 2016-12-26 | |
dc.description.abstract | Interplay among immune activation and cancer pathogenesis provides the framework for a novel subspecialty known as immunooncology. In the rapidly evolving field of immunooncology, understanding the tumor-specific immune response enhances understanding of cancer resistance. This review highlights the fundamentals of incorporating precision medicine to discover new immune biomarkers and predictive signatures. Using a personalized approach may have a significant, positive impact on the use of oncolytics to better guide safer and more effective therapies. | en_US |
dc.identifier.citation | Pandya, P. H., Murray, M. E., Pollok, K. E., & Renbarger, J. L. (2016). The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches. Journal of Immunology Research, 2016, 4273943. http://doi.org/10.1155/2016/4273943 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/12437 | |
dc.language.iso | en_US | en_US |
dc.publisher | Hindawi | en_US |
dc.relation.isversionof | 10.1155/2016/4273943 | en_US |
dc.relation.journal | Journal of Immunology Research | en_US |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 United States | |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/3.0/us/ | |
dc.source | PMC | en_US |
dc.subject | Immune activation | en_US |
dc.subject | Cancer pathogenesis | en_US |
dc.subject | Immunooncology | en_US |
dc.subject | Cancer resistance | en_US |
dc.title | The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches | en_US |
dc.type | Article | en_US |